{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:45:01Z","timestamp":1773294301199,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T00:00:00Z","timestamp":1594512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100008771","name":"Tourette Association of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006324","name":"American Psychological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005339","name":"American Academy of Neurology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH073517"],"award-info":[{"award-number":["T32MH073517"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41386-020-0762-4","type":"journal-article","created":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T12:02:22Z","timestamp":1594555342000},"page":"2114-2119","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Optimizing behavior therapy for youth with Tourette\u2019s disorder"],"prefix":"10.1038","volume":"45","author":[{"given":"Joseph F.","family":"McGuire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1854-2337","authenticated-orcid":false,"given":"Nathaniel","family":"Ginder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesley","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7802-4200","authenticated-orcid":false,"given":"Joey Ka-Yee","family":"Essoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J.","family":"Ricketts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T.","family":"McCracken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,12]]},"reference":[{"key":"762_CR1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10578-010-0211-4","volume":"42","author":"CA Conelea","year":"2011","unstructured":"Conelea CA, Woods DW, Zinner SH, Budman C, Murphy T, Scahill LD, et al. Exploring the impact of chronic tic disorders on youth: results from the Tourette syndrome impact survey. Child Psychiatry Hum Dev. 2011;42:219\u201342.","journal-title":"Child Psychiatry Hum Dev"},{"key":"762_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jpsychires.2013.12.009","volume":"50","author":"JF McGuire","year":"2014","unstructured":"McGuire JF, Piacentini J, Brennan EA, Lewin AB, Murphy TK, Small BJ, et al. A meta-analysis of behavior therapy for Tourette Syndrome. J Psychiatr Res. 2014;50:106\u201312.","journal-title":"J Psychiatr Res"},{"key":"762_CR3","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.jaac.2013.09.015","volume":"52","author":"TK Murphy","year":"2013","unstructured":"Murphy TK, Lewin AB, Storch EA, Stock S. Practice parameter for the assessment and treatment of children and adolescents with tic disorders. J Am Acad Child Adolesc Psychiatry. 2013;52:1341\u201359.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"762_CR4","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.0000000000007467","volume":"92","author":"T Pringsheim","year":"2019","unstructured":"Pringsheim T, Holler-Managan Y, Okun MS, Jankovic J, Piacentini J, Cavanna AE, et al. Comprehensive systematic review summary: treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology 2019;92:907\u201315.","journal-title":"Neurology"},{"key":"762_CR5","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1001\/jama.2010.607","volume":"303","author":"J Piacentini","year":"2010","unstructured":"Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303:1929\u201337.","journal-title":"JAMA."},{"key":"762_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jpsychores.2008.04.010","volume":"65","author":"CA Conelea","year":"2008","unstructured":"Conelea CA, Woods DW. The influence of contextual factors on tic expression in Tourette\u2019s syndrome: a review. J Psychosom Res. 2008;65:487\u201396.","journal-title":"J Psychosom Res"},{"key":"762_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/753020","volume":"2014","author":"DJV Beetsma","year":"2014","unstructured":"Beetsma DJV, van den Hout MA, Engelhard IM, Rijkeboer MM, Cath DC. Does repeated ticking maintain tic behavior? An experimental study of eye blinking in healthy individuals. Behav Neurol. 2014;2014:1\u20137.","journal-title":"Behav Neurol."},{"key":"762_CR8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1177\/0145445514531015","volume":"38","author":"MR Capriotti","year":"2014","unstructured":"Capriotti MR, Brandt BC, Turkel JE, Lee H-J, Woods DW. Negative reinforcement and premonitory urges in youth with Tourette syndrome: an experimental evaluation. Behav Modif. 2014;38:276\u201396.","journal-title":"Behav Modif."},{"key":"762_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/0014-2999(94)90687-4","volume":"257","author":"D Quartermain","year":"1994","unstructured":"Quartermain D, Mower J, Rafferty MF, Herting RL, Lanthorn TH. Acute but not chronic activation of the NMDA-coupled glycine receptor with d-cycloserine facilitates learning and retention. Eur J Pharmacol. 1994;257:7\u201312.","journal-title":"Eur J Pharmacol"},{"key":"762_CR10","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.biopsych.2008.01.012","volume":"63","author":"MM Norberg","year":"2008","unstructured":"Norberg MM, Krystal JH, Tolin DF. A meta-analysis of d-cycloserine and the facilitation of fear extinction and exposure therapy. Biol Psychiatry. 2008;63:1118\u201326.","journal-title":"Biol Psychiatry."},{"key":"762_CR11","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4088\/JCP.15r10334","volume":"78","author":"JF McGuire","year":"2017","unstructured":"McGuire JF, Wu MS, Piacentini J, McCracken JT, Storch EA. A meta-analysis of d-cycloserine in exposure-based treatment: moderators of treatment efficacy, response, and diagnostic remission. J Clin Psychiatry. 2017;78:196\u2013206.","journal-title":"J Clin Psychiatry"},{"key":"762_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1001\/jamapsychiatry.2016.3955","volume":"74","author":"D Mataix-Cols","year":"2017","unstructured":"Mataix-Cols D, Cruz LF, de la, Monzani B, Rosenfield D, Andersson E, P\u00e9rez-Vigil A, et al. d-cycloserine augmentation of exposure-based cognitive behavior therapy for anxiety, obsessive-compulsive, and posttraumatic stress disorders: a systematic review and meta-analysis of individual participant data. JAMA Psychiatry. 2017;74:501\u201310.","journal-title":"JAMA Psychiatry"},{"key":"762_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","volume":"28","author":"JF Leckman","year":"1989","unstructured":"Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566\u201373.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"762_CR14","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1037\/1040-3590.17.4.486","volume":"17","author":"EA Storch","year":"2005","unstructured":"Storch EA, Murphy TK, Geffken GR, Sajid M, Allen P, Roberti JW, et al. Reliability and validity of the Yale Global Tic Severity Scale. Psychol Assess. 2005;17:486\u201391.","journal-title":"Psychol Assess."},{"key":"762_CR15","doi-asserted-by":"publisher","first-page":"e1711","DOI":"10.1212\/WNL.0000000000005474","volume":"90","author":"JF McGuire","year":"2018","unstructured":"McGuire JF, Piacentini J, Storch EA, Murphy TK, Ricketts EJ, Woods DW, et al. A multicenter examination and strategic revisions of the Yale Global Tic Severity Scale. Neurology. 2018;90:e1711\u2013e1719.","journal-title":"Neurology."},{"key":"762_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/00004583-199205000-00013","volume":"31","author":"JT Walkup","year":"1992","unstructured":"Walkup JT, Rosenberg LA, Brown J, Singer HS. The validity of instruments measuring tic severity in Tourette\u2019s syndrome. J Am Acad Child Adolesc Psychiatry. 1992;31:472\u20137.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"762_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.brat.2015.05.006","volume":"70","author":"JF McGuire","year":"2015","unstructured":"McGuire JF, Piacentini J, Scahill L, Woods DW, Villarreal R, Wilhelm S, et al. Bothersome tics in patients with chronic tic disorders: characteristics and individualized treatment response to behavior therapy. Behav Res Ther. 2015;70:56\u201363.","journal-title":"Behav Res Ther"},{"key":"762_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jpsychires.2016.09.007","volume":"83","author":"JF McGuire","year":"2016","unstructured":"McGuire JF, McBride N, Piacentini J, Johnco C, Lewin AB, Murphy TK, et al. The premonitory urge revisited: an individualized premonitory urge for tics scale. J Psychiatr Res. 2016;83:176\u201383.","journal-title":"J Psychiatr Res"},{"key":"762_CR19","doi-asserted-by":"publisher","first-page":"102149","DOI":"10.1016\/j.janxdis.2019.102149","volume":"68","author":"D Rosenfield","year":"2019","unstructured":"Rosenfield D, Smits JAJ, Hofmann SG, Mataix-Cols D, de la Cruz LF, Andersson E, et al. Changes in dosing and dose timing of d-cycloserine explain Its apparent declining efficacy for augmenting exposure therapy for anxiety-related disorders: an individual participant-data meta-analysis. J Anxiety Disord. 2019;68:102149.","journal-title":"J Anxiety Disord"},{"key":"762_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1212\/WNL.0000000000003710","volume":"88","author":"DG Sukhodolsky","year":"2017","unstructured":"Sukhodolsky DG, Woods DW, Piacentini J, Wilhelm S, Peterson AL, Katsovich L, et al. Moderators and predictors of response to behavior therapy for tics in Tourette syndrome. Neurology. 2017;88:1029\u201336.","journal-title":"Neurology."},{"key":"762_CR21","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.biopsych.2010.07.015","volume":"68","author":"EA Storch","year":"2010","unstructured":"Storch EA, Murphy TK, Goodman WK, Geffken GR, Lewin AB, Henin A, et al. A preliminary study of d-cycloserine augmentation of cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2010;68:1073\u20136.","journal-title":"Biol Psychiatry"},{"key":"762_CR22","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/jamapsychiatry.2016.1128","volume":"73","author":"EA Storch","year":"2016","unstructured":"Storch EA, Wilhelm S, Sprich S, Henin A, Micco J, Small BJ, et al. Efficacy of augmentation of cognitive behavior therapy with weight-adjusted d-cycloserine vs placebo in pediatric obsessive-compulsive disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73:779\u201388.","journal-title":"JAMA Psychiatry"},{"key":"762_CR23","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/da.22389","volume":"32","author":"JF McGuire","year":"2015","unstructured":"McGuire JF, Piacentini J, Lewin AB, Brennan EA, Murphy TK, Storch EA. A meta-analysis of cognitive behavior therapy and medication for child obsessive\u2013compulsive disorder: moderators of treatment efficacy, response, and remission. Depress Anxiety. 2015;32:580\u201393.","journal-title":"Depress Anxiety"},{"key":"762_CR24","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1089\/cap.2010.0149","volume":"21","author":"EA Storch","year":"2011","unstructured":"Storch EA, De Nadai AS, Lewin AB, McGuire JF, Jones AM, Mutch PJ, et al. Defining treatment response in pediatric tic disorders: a signal detection analysis of the Yale Global Tic Severity Scale. J Child Adolesc Psychopharmacol. 2011;21:621\u20137.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"762_CR25","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.cct.2013.08.012","volume":"36","author":"S Jeon","year":"2013","unstructured":"Jeon S, Walkup JT, Woods DW, Peterson A, Piacentini J, Wilhelm S, et al. Detecting a clinically meaningful change in tic severity in Tourette syndrome: a comparison of three methods. Contemp Clin Trials. 2013;36:414\u201320.","journal-title":"Contemp Clin Trials"},{"key":"762_CR26","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/0269881116658988","volume":"30","author":"J G\u00fcnthner","year":"2016","unstructured":"G\u00fcnthner J, Scholl J, Favaron E, Harmer CJ, Johansen-Berg H, Reinecke A. The NMDA receptor partial agonist d-cycloserine does not enhance motor learning. J Psychopharmacol 2016;30:994\u20139.","journal-title":"J Psychopharmacol"},{"key":"762_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pediatrneurol.2015.02.002","volume":"52","author":"ME Lemmon","year":"2015","unstructured":"Lemmon ME, Grados M, Kline T, Thompson CB, Ali SF, Singer HS. Efficacy of glutamate modulators in tic suppression: a double-blind, randomized control trial of D-serine and riluzole in Tourette syndrome. Pediatr Neurol. 2015;52:629\u201334.","journal-title":"Pediatr Neurol."},{"key":"762_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bbr.2018.03.037","volume":"347","author":"SA George","year":"2018","unstructured":"George SA, Rodriguez-Santiago M, Riley J, Abelson JL, Floresco SB, Liberzon I. D-cycloserine facilitates reversal in an animal model of post-traumatic stress disorder. Behav Brain Res. 2018;347:332\u20138.","journal-title":"Behav Brain Res"},{"key":"762_CR29","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainresbull.2013.12.007","volume":"105","author":"PJ Fitzgerald","year":"2014","unstructured":"Fitzgerald PJ, Seemann JR, Maren S. Can fear extinction be enhanced? A review of pharmacological and behavioral findings. Brain Res Bull. 2014;105:46\u201360.","journal-title":"Brain Res Bull"},{"key":"762_CR30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1176\/appi.ajp.159.3.480","volume":"159","author":"U Heresco-Levy","year":"2002","unstructured":"Heresco-Levy U, Ermilov M, Shimoni J, Shapira B, Silipo G, Javitt DC. Placebo-controlled trial of d-cycloserine added to conventional neuroleptics, olanzapine, or risperidone in schizophrenia. Am J Psychiatry. 2002;159:480\u20132.","journal-title":"Am J Psychiatry"},{"key":"762_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0893-133X(99)00014-7","volume":"21","author":"B van Berckel","year":"1999","unstructured":"van Berckel B, Evenblij CN, van Loon B, Maas MF, van der Geld M, Wynne HJ, et al. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study. Neuropsychopharmacology. 1999;21:203\u201310.","journal-title":"Neuropsychopharmacology."}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0762-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-020-0762-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:09:18Z","timestamp":1684616958000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-020-0762-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["762"],"URL":"https:\/\/doi.org\/10.1038\/s41386-020-0762-4","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,12]]},"assertion":[{"value":"4 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}